Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Harvard Business School
Medtronic
US Army
Boehringer Ingelheim

Generated: April 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ganitumab

« Back to Dashboard

US Patents for Ganitumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ganitumab ➤ Try a Free Trial Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Try a Free Trial
Ganitumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Ganitumab ➤ Try a Free Trial P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial
Ganitumab ➤ Try a Free Trial Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Try a Free Trial
Ganitumab ➤ Try a Free Trial Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Try a Free Trial
Ganitumab ➤ Try a Free Trial Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein CureVac AG (Tubingen, DE) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for Ganitumab

Drugname Country Document Number Estimated Expiration Related US Patent
Ganitumab Canada 2900764 2033-02-08 ➤ Try a Free Trial
Ganitumab European Patent Office 2954056 2033-02-08 ➤ Try a Free Trial
Ganitumab Hong Kong 1218930 2033-02-08 ➤ Try a Free Trial
Ganitumab Japan 2016509014 2033-02-08 ➤ Try a Free Trial
Ganitumab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Try a Free Trial
Ganitumab Australia 2013220749 2032-02-15 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Citi
Colorcon
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.